NeoTYPE Cancer Profiles

NeoTYPE™ Cancer Profiles are multi-method test panels, custom-designed for a specific tumor type, that identify the genetic changes most significant to therapy decisions, prognosis, and clinical research. Read more.


Methodology Test Name Test Description Results per page:
NeoTYPE Profiles NeoTYPE™ AML Favorable-Risk Profile This test is performed by sequencing of select exons of the genes FLT3 and KIT. Test orders include summary interpretation of all results together. Individual genes from a validated list of myeloid genes can be added-on. In addition, the genes listed above can be ordered separately and will be reported individually without summary interpretation.
NeoTYPE Profiles NeoTYPE™ Cancer Exome Profile The NeoTYPE Cancer Exome Profile is performed by massive parallel sequencing of the coding regions in 4813 different cancer related genes. Test orders include summary interpretation of all results together.
NeoTYPE Profiles NeoTYPE™ CLL Prognostic Profile This test is performed by the sequencing of select exons of the genes listed, plus the CLL FISH Panel and ZAP-70 flow cytometry as noted. IgVH Mutation, MYD88, NOTCH1, SF3B1, TP53. Individual genes from a validated list of myeloid genes can be added-on. Test orders include summary interpretation of all results together. FISH / Flow components of NeoTYPE Profiles may be ordered as "Tech-Only" by pathology clients who wish to perform the professional component. Any tests may be ordered separately; these will be reported individually without summary interpretation.
NeoTYPE Profiles NeoTYPE™ JMML Profile This test is performed by the sequencing of select exons of the genes listed. BRAF, CBL, CEBPA, FLT3, HRAS, JAK2 V617F, JAK2 Exon 12+14, JAK3, KIT, KRAS, NPM1, NRAS, PDGFRA, PTEN, PTPN11, SETBP1, PTEN FISH. Individual genes from a validated list of myeloid genes can be added-on. Test orders include summary interpretation of all results together. FISH / Flow components of NeoTYPE Profiles may be ordered as "Tech-Only" by pathology clients who wish to perform the professional component. Any tests may be ordered separately; these will be reported individually without summary interpretation.
NeoTYPE Profiles NeoTYPE™ Lymphoma Profile This test is performed by the sequencing of select exons of the genes listed. BCL1, BCL2, BRAF, CARD11, CD79B, EZH2, MYD88 and NRAS. Individual genes from a validated list of myeloid genes can be added-on. Test orders include summary interpretation of all results together. Any tests may be ordered separately; these will be reported individually without summary interpretation.
NeoTYPE Profiles NeoTYPE™ MPN Profile This test is performed by the sequencing of select exons of the genes listed unless another method is noted. ABL1, ASXL1, BRAF, CALR, CEBPA, CSF3R, EZH2, FLT3, HRAS, IDH1, IDH2, JAK2 V617F, JAK2 Exon 12+14, KIT, KRAS, MPL, NPM1, NRAS, PDGFRA, PTEN, PTPN11, SETBP1, SRSF2, TET2, U2AF1 and PTEN FISH. Individual genes from a validated list of myeloid genes can be added-on. Test orders include summary interpretation of all results together. FISH / Flow components of NeoTYPE Profiles may be ordered as "Tech-Only" by pathology clients who wish to perform the professional component. Any tests may be ordered separately; these will be reported individually without summary interpretation.
NeoTYPE Profiles NeoTYPE™ Myeloid Disorders Profile This test is performed by the sequencing of select exons of the genes listed. ABL1, ASXL1, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, CUX1, DNMT3A, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, JAK2 V617F, JAK2 Exon 12+14, JAK3, KDM6A, KIT, KRAS, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2. Test orders include summary interpretation of all results together. Tests may be ordered individually; these will be reported individually without summary interpretation.